These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7801672)

  • 21. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Present and future of oral anticoagulants].
    Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
    Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring anticoagulant therapy by measuring haemostatic parameters.
    Chek JB
    East Afr Med J; 1997 Jan; 74(1):1-2. PubMed ID: 9145566
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term oral coagulation. Self monitoring prevents complication].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813982
    [No Abstract]   [Full Text] [Related]  

  • 25. PPSB as first choice treatment in the reversal of oral anticoagulant therapy.
    Strengers PF; Drenth JC
    Acta Anaesthesiol Belg; 2002; 53(3):183-6. PubMed ID: 12461827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral anticoagulant therapy for patients with atrial fibrillation--an update.
    Hylek EM
    Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205
    [No Abstract]   [Full Text] [Related]  

  • 27. How can we improve our use of oral anticoagulants?
    Alpert JS
    Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
    [No Abstract]   [Full Text] [Related]  

  • 28. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
    Casimire T; Carter R; Peters S; Tweedle J; Charles KS
    Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monitoring of coagulation during treatment with direct oral anticoagulants].
    Kasper A; Lindhoff-Last E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1997-2000. PubMed ID: 24065404
    [No Abstract]   [Full Text] [Related]  

  • 32. [Individual laboratory control of anticoagulant therapy].
    Spannagl M; Lill H; Trauner A; Schramm W
    Vasa Suppl; 1992; 35():115-6. PubMed ID: 1481011
    [No Abstract]   [Full Text] [Related]  

  • 33. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of the diagnosis and treatment of venous thrombosis. Biological monitoring of anticoagulant treatment].
    De Moerloose P
    Rev Med Suisse Romande; 1995 Apr; 115(4):295-6. PubMed ID: 7740252
    [No Abstract]   [Full Text] [Related]  

  • 37. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial.
    van Aart L; Eijkhout HW; Kamphuis JS; Dam M; Schattenkerk ME; Schouten TJ; Ploeger B; Strengers PF
    Thromb Res; 2006; 118(3):313-20. PubMed ID: 16182346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors.
    Hylek EM
    Semin Vasc Med; 2003 Aug; 3(3):271-8. PubMed ID: 15199460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heparin and monitoring of peroral anticoagulant therapy].
    Bremmelgaard A
    Ugeskr Laeger; 1986 May; 148(21):1275-6. PubMed ID: 3727111
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anticoagulation in the elderly--a thin line between benefit and risk].
    Steffel J; Lüscher TF
    MMW Fortschr Med; 2009 Apr; 151(16):33-6. PubMed ID: 19658293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.